1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INCYTE CORP.
Incyte Corp. XNAS: INCY
70.81 3.26 (4.83%)
3.0M
XNAS Volume

XNAS 26 Jun, 2025 4:04 PM (EDT)

CEO Appointment
Incyte rises as it appoints Bill Meury as its CEO, succeeding Herve Hoppenot, effective immediately See details

Detailed Stock Analysis for Incyte Corp. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in